touchPODCAST

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies

touchIN CONVERSATION for touchONCOLOGY

Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 

The experts

• Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
• Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: 

https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/

 

Early diagnosis and treatment of NMOSD: Practical insights

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights

Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.

The experts:

• Prof. John Chen - Mayo Clinic, Rochester, MN, USA
• Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment

Early diagnosis and treatment of NMOSD: Practical insights

touchIN CONVERSATION for touchOPTHAMOLOGY

Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.

The experts:

• Prof. John Chen - Mayo Clinic, Rochester, MN, USA
• Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 1 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Pathologist: Dr Eric Gars, Gainesville, FL, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. 

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
• Critical care pharmacist: Prof. Rob MacLaren, Denver, CO

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting Best practice for the multidisciplinary team - Part 1 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Pathologist: Dr Eric Gars, Gainesville, FL, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. 

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
• Critical care pharmacist: Prof. Rob MacLaren, Denver, CO

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.